ISB News

Former SEE intern Julia Joo thanks ISB

“I’m so grateful to ISB for giving me the opportunity to build the diverse lab-relevant skillset that made me a competitive candidate for research labs as an undergraduate,” said Julia Joo, who recently visited ISB and reflected on how her Systems Education Experiences internships shaped her academic and professional trajectory.

Julia JooIn 2013, Joo was a high school intern in ISB’s Hood Lab. In 2014, she came back for another internship, this time in the Huang Lab. Joo has since graduated from the University of Washington with a Biochemistry and Molecular, Cellular and Development Biology double major, and now she’s working at Seattle Children’s Research Institute Center for Immunity and Immunotherapies in the Miao Lab.

“With my experience in a cutting-edge research facility like ISB, I was able to be selective in choosing the lab I decided to join from those which offered me a position. I was incredibly fortunate to work on a project studying the sub-clonal variation of mutation spectra in glioblastoma tumors with Dr. Lawrence Loeb, the pioneer of the mutator phenotype hypothesis of cancer. I have ISB to thank for this experience, as I initially encountered Dr. Loeb’s work at the annual ISB Symposium in 2013, at which he was a keynote speaker.”

“Even years after my internship, I am constantly struck by the relevance of ISB’s mantra of using interdisciplinary methods to illuminate the complex networks of disease. The systems approach to biomedicine motivates me to learn new techniques across disciplines and deepen my understanding of coding languages so I can be better equipped to tackle the hurdle of heterogeneity of diseases between and within individual patients.”

“I am fascinated by the bridge between research and patient care, and thus am very excited to dive into the world of translational research as a Research Scientist in Dr. Carol Miao’s lab at the Seattle Children’s Research Institute. I’m thrilled to be designing immunotherapies for genetic diseases like hemophilia, knowing that my work will soon lead to real treatments that will help kids and adults alike to live safer and healthier lives.”

Recent Articles

  • View of the responsive recruitment website and electronic consent platform as seen on mobile phone and desktop devices.

    ISB Builds Digital Platform for COVID-19 Research Study – and Beyond

    In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.

  • Reshaping STEM Education Toward a More Equitable Future for Students

    ISB Assistant Professor Dr. Sean Gibbons recently participated in a virtual event titled “Reshaping STEM Education Toward Equitable Futures for Washington Students.” Panelists shared their insights about how to leverage this complex moment to reshape STEM education toward equity, sustainability, and prosperity for Washington state’s students — especially those furthest from opportunity.

  • Shmulevich-Thorsson

    ISB Researchers Among Recipients of AACR Team Science Award

    The American Association for Cancer Research (AACR) has recognized The Cancer Genome Atlas (TCGA) project with the 2020 AACR Team Science Awards. Award recipients include Dr. Ilya Shmulevich, ISB professor and head of the Shmulevich Lab; ISB senior research scientist Dr. Vésteinn Þórsson; and former Shmulevich Lab members Drs. Brady Bernard and Theo Knijnenburg.